Stock Market - AMC filed to the SEC...THAT THE VOTE TO APPROVE 500MIL SHARES IS NOT HAPPENING!! �������� |
- AMC filed to the SEC...THAT THE VOTE TO APPROVE 500MIL SHARES IS NOT HAPPENING!! ��������
- The Psychedelic Renaissance: A Case for $MNMD
- Nano Dimension Acquires Micro Mechanics 3D-Printing Leader, NanoFabrica Ltd.
- Many Experts Questioned Why The Tech Giants Like Musk And Dorsey Thinks Bitcoin Is More Environmentally Friendly
- AMC Theater Chain Yanks Plan to Issue 500 Million New Shares
- Ireland: Operating A Cryptocurrency Company Without Registration With The Central Bank Is A Crime
- CCP "Global News" on Tesla - "sales in China are doomed to experience a sharp fall in the second quarter"
- After hours scanning.
- The Plague Haunting Online Financial Communities
- Market Open - 4/27
- Starting to get more data on SwingBot’s performance. Finding that it’s got an ~80% win rate in the first half of the day and ~70% in the second. All of these trades were alerted based on the same set of rules. Stop levels are subjective.
- Reed's Inc.(R) Expands Distribution With Defense Commissary Agency
- Taking a step back.
- Here is a Market Recap for today Tuesday, April 27, 2021
- My Watchlist For 4/27/2021 -- Sorry I was on vacation
- Biden to Omit Estate-Tax Expansion from Coming Economic Plan
- ETF Heatmap (category/sector/country) - April 27, 2021 at close
- How to Profit From Unusual Options Activity - Complete Guide
- $NAOV- Potential Gem Under The Radar
- My Watchlist for 4/28/2021 -- Bruce Swingsteen Is In The House
- How to Use SweepCast & What is Sentiment
| AMC filed to the SEC...THAT THE VOTE TO APPROVE 500MIL SHARES IS NOT HAPPENING!! �������� Posted: 27 Apr 2021 03:50 PM PDT
 | ||
| The Psychedelic Renaissance: A Case for $MNMD Posted: 27 Apr 2021 06:12 AM PDT The name of the company: MindMedicine. All of this isn't financial advice. I strongly recommend reading the whole post but if you're lazy there is a TL;DR at the bottom. About the company The goal of this company (and sector) is to revolutionize mental healthcare. How do they want to do this? MindMed focuses on different psychedelic drugs including Psilocybin, LSD, DMT and the Ibogaine derivative 18-MC (18-MC has huge potential in opioid withdrawal therapy and doesn't have the side effects of Ibogaine). These drugs are currently being tested in numerous trials to ensure that the treatment methods are effective and safe, but everyone that has ever taken any kind of psychedelics knows about the immense potential which these kind of drugs have. The drugs address all kinds of mental health problems including Depression, PTSD, Anxiety and Addiction. And not one of these mental health problems is becoming less common, Corona and shit makes our mental health even worse by the day. Are there effective drugs already on the market to treat these diseases? Not really, instead opioid addictions are growing faster than ever and there is no real solution - apart from psychedelics. To make the treatment as individual as possible MNMD has a project called "Albert" where they work with AI/machine learning, this is really a big factor because they are already getting all the data they need from the trials. The CEO himself has said that this is a company equally specialized in technology and in pharma. He called MindMed the „Tesla of Mental Health", I think this describes MindMed best. The company also has a crazy good team, they got ex Google and Pfizer employees. Previous Research Psychedelics in the mental health sector are not a completely new idea, this topic has been researched a lot in the 1950's and 1960's. There are a lot of studies from that time indicating the positive effects of these drugs in patients with different mental health disorders. But because of the Criminalisation of psychedelics in the western world beginning in the 1960's, this topic was not picked up by researchers until the 1990's. Since then multiple studies have been made and are currently happening. Recent studies have shown that low doses of psilocybin are as effective as the industry standard SSRIs! Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder Trial of Psilocybin versus Escitalopram for Depression Effects of psychedelics on the brain Ibogaine and MindMed´s derivative 18-MC Effects of MDMA-assisted therapy Financials Okay the drugs are great blabla, what about the financials tho? How can they afford these incredibly expensive trials? The answer: they got a ton of cash from previous offerings, the latest number i could find was $161 Mio USD. This will finance the company in the coming years. Will they have to raise more money eventually? Maybe, but right now they are good. As soon as the first drugs get approved, this company will make a lot of money, not because they are exploitative but because the market for mental health disorders is huge (it's about $20 billion right now and this number is growing rapidly). Competition Okay all looking beautiful, but what about the competition? What if MNMD just isn't the company that is developing the best product for the market? Let me put it this way; Mind Medicine is the undisputed leader in this emerging sector right now. The second biggest player (looking at MarketCap, trials and cash available) is Compass Pathways. There are many reasons why I personally would not invest in this company; first of all they have much fewer trials going on. If I'm already investing in a very risky company, I want to choose the one that is most likely going to succeed. And in the pharma industry you can lower that risk by investing in a company which is developing many different drugs/treatments (MindMed has over 10 trials going on, CMPS has only one), this way if one trial fails the company won't go bankrupt. Even if they only get one drug approved they will be doing great, we're still talking about a growing market worth Billions. Another thing is Compass´attempt at patenting shit like the color of the walls and other ridiculous stuff, I personally can't invest in them because of my moral standards. Celebrities Everyone investing in stocks knows that Musk's tweets are more important than fundamentals, that's why I have to mention this. Cathie Wood has heard about this, she didn't directly say she would invest in this company but she knows about the disruptive potential of this company, and is there a more fitting stock for the ARK Innovation ETF out there? Kevin O'Leary aka Mr. Wonderful has been supporting this company since early last year, even if you do not like him you have to admit that he has quite a lot of publicity. The company is also doing a lot of PR, with the CEO JR Rahn giving numerous interviews within the last months. NASDAQ $MNMD is the ticker. https://www.nasdaq.com/market-activity/stocks/mnmd Further Information There are many catalysts coming up this year, the most important ones are obviously the trial results. The next major catalyst after Today should be the Special Meeting of the company on the 27th of May. The MNMD homepage has a great Investors section where you can find all the press releases and important dates of the company. If you are very interested in MNMD, go join r/MindMedInvestorsClub ! 𝗧𝗟;𝗗𝗥 The shift to psychedelics in mental healthcare (100B+ industry) will be massive, there are millions of patients out there waiting for a treatment method that works! MindMed, the leader of this sector will uplist on the NASDAQ today. I wish all of you best luck this week, may the shroom boom bless us with some nice gains. 🚀🚀🚀 [link] [comments]  | ||
| Nano Dimension Acquires Micro Mechanics 3D-Printing Leader, NanoFabrica Ltd. Posted: 27 Apr 2021 01:01 PM PDT
 | ||
| Posted: 27 Apr 2021 10:26 AM PDT
 | ||
| AMC Theater Chain Yanks Plan to Issue 500 Million New Shares Posted: 27 Apr 2021 04:43 PM PDT
 | ||
| Ireland: Operating A Cryptocurrency Company Without Registration With The Central Bank Is A Crime Posted: 27 Apr 2021 06:03 AM PDT
 | ||
| Posted: 27 Apr 2021 09:21 AM PDT
 | ||
| Posted: 27 Apr 2021 06:00 PM PDT
 | ||
| The Plague Haunting Online Financial Communities Posted: 27 Apr 2021 01:49 PM PDT One of the simplest ways to get rich is to convince others that paying you, will make you rich. It is a tale as old as time, selling the shovel is more profitable than digging for gold. The Plague Haunting Online Financial Communities - DecentraNews There is nothing wrong with this tactic as it is a valid way to make a living, however, nowadays it is considerably more sinister when enacted. In this day and age of financial gurus and people attempting to sell you a service, there considerable and deliberate attempts to mislead due to the potential monetary gains. It does not matter what platform you are on, you will see the attempts to profit off your small knowledge on the subject and your general naïve. Due to the nature of options only having the potential to lose 100% and having unlimited upside potential, the data points are skewed upwards, which as we discussed above, is also skewed higher than it ought to be. The true way in which the data should be calculated is median, which would still be skewed due to options nature of only having -100% downside, however, that is unlikely due to the profitability in misleading the public with the skewed max average return number. This nasty problem plaguing the online Financial community is one we have to attempt to eliminate. The true motives of a majority of these people are to sell you a product and it is clear. The only thing that these people care about is making money from selling their service. [link] [comments]  | ||
| Posted: 27 Apr 2021 06:43 AM PDT
 | ||
| Posted: 27 Apr 2021 07:15 PM PDT
 | ||
| Reed's Inc.(R) Expands Distribution With Defense Commissary Agency Posted: 27 Apr 2021 01:53 PM PDT
 | ||
| Posted: 27 Apr 2021 11:15 AM PDT
 | ||
| Here is a Market Recap for today Tuesday, April 27, 2021 Posted: 27 Apr 2021 01:42 PM PDT PsychoMarket Recap - Tuesday, April 27, 2021 Stocks turned modestly lower Tuesday, as market participants awaited for more corporate earnings results and commentary from members of the Federal Open Market Committee (FOMC), including Federal Reserve Chair Jerome Powell. This week, a slew of huge companies are set to report corporate earnings for the first quarter of 2021. Altogether, the market caps of the companies reporting this week comprise nearly half the total market cap of the S&P 500, according to FactSet. So far, the vast majority of companies have vastly exceeded analyst estimates, with effective vaccine distribution in the US helping stoke demand as the economy gradually reopens. Eighty-four percent of the S&P 500 companies that have reported first-quarter results to date posted a positive earnings per share surprise, according to data from FactSet. This would mark the highest percentage of companies reporting upside surprises since FactSet began tracking this metric in 2008, assuming this beat rate holds through the end of earnings season. Today kicked off the first of the FOMC's two-day rate-setting meeting. The event is extremely unlikely to lead to any major shifts in monetary policy, with officials reiterating their commitment to keeping policy highly accommodative as the economy continues to recover from the pandemic. This includes maintaining interest rates near zero and maintaining an aggressive asset purchasing program at a monthly rate of $120 billion. In an earlier meeting, Powell said the Central Bank would slow the pace of its bond purchase program "well before" raising interest rates. Powell said, "We will taper asset purchases when we've made substantial further progress toward our goals from last December when we announced that guidance. That would in all likelihood be well before the time we consider raising rates." In other news, according to a report by the Conference Board, consumer confidence has surged to a 14-month high in April as effective distribution of the vaccine and easing of social distancing guidelines in the US allows for the economy to gradually reopen. The Conference Board's monthly consumer confidence index jumped to a reading of 121.7 in April, or well above the 113.0 expected. Lynn Franco, senior director of economic indicators at the Conference Board, said in a statement, "Consumers' assessment of current conditions improved significantly in April, suggesting the economic recovery strengthened further in early Q2. Consumers' optimism about the short-term outlook held steady this month. Consumers were more upbeat about their income prospects, perhaps due to the improving job market and the recent round of stimulus checks." Highlights
"An investment in knowledge pays the best interest." — Benjamin Franklin [link] [comments]  | ||
| My Watchlist For 4/27/2021 -- Sorry I was on vacation Posted: 27 Apr 2021 05:59 AM PDT
 | ||
| Biden to Omit Estate-Tax Expansion from Coming Economic Plan Posted: 27 Apr 2021 04:43 PM PDT
 | ||
| ETF Heatmap (category/sector/country) - April 27, 2021 at close Posted: 27 Apr 2021 01:45 PM PDT
 | ||
| How to Profit From Unusual Options Activity - Complete Guide Posted: 27 Apr 2021 01:33 PM PDT
 | ||
| $NAOV- Potential Gem Under The Radar Posted: 27 Apr 2021 10:43 AM PDT NanoVibronix Inc. (NASDAQ: NAOV) is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, which is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave (SAW) technology. This technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home without the assistance of medical professionals. The Company's primary products include PainShield®, UroShield™ and WoundShield™. They have a special shareholders meeting taking place on May 6th to address the authorization of new shares due to conversion of warrants into shares. Upon first news of this it shot up 300% and has fallen back to retest support levels. Current price $1.06. Huge potential upside if the vote goes through and could easily slide 50%+ after the vote has convened. Analyst put target price at $10.50 with a short term target of $3. [link] [comments]  | ||
| My Watchlist for 4/28/2021 -- Bruce Swingsteen Is In The House Posted: 27 Apr 2021 05:18 PM PDT
 | ||
| How to Use SweepCast & What is Sentiment Posted: 27 Apr 2021 01:27 PM PDT
 |
![[link]](https://i.redd.it/jv0ya1d7psv61.jpg){kind=link}
![[link]](https://i.redd.it/e6pb8i6ozpv61.png){kind=link}
![[link]](https://i.redd.it/48sr9yjuptv61.jpg){kind=link}
![[link]](https://i.redd.it/rlunukru2sv61.png){kind=link}
| You are subscribed to email updates from r/StockMarket - Reddit's Front Page of the Stock Market. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment